PT  - JOURNAL ARTICLE
AU  - JENETTE CREANEY
AU  - IAN M. DICK
AU  - JUSTINE S. LEON
AU  - BRUCE W.S. ROBINSON
TI  - A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ
DP  - 2017 Mar 01
TA  - Cancer Genomics - Proteomics
PG  - 103--117
VI  - 14
IP  - 2
4099  - http://cgp.iiarjournals.org/content/14/2/103.short
4100  - http://cgp.iiarjournals.org/content/14/2/103.full
SO  - Cancer Genomics Proteomics2017 Mar 01; 14
AB  - Backgound/Aim: Malignant mesothelioma (MM) is an aggressive and fatal pleural cancer. The cell secretome offers information allowing insight into the pathogenesis of MM while offering the possibility to identify potential therapeutic targets and biomarkers. In the present study the secretome protein profile of MM cell lines was compared to normal mesothelial cells. Materials and Methods: Six MM cell lines were compared against three primary mesothelial cell culture preparations using iTRAQ® mass spectrometry. Results: MM cell lines more abundantly secreted exosome-associated proteins than mesothelial cells. MM cell secretomes were enriched in proteins that are involved in response to stress, carbon metabolism, biosynthesis of amino acids, antigen processing and presentation and protein processing in the endoplasmic reticulum. Conclusion: The MM cell secretome is enriched in proteins that are likely to enhance its growth and response to stress and help it inhibit an adaptive immune response. These are potential targets for therapeutic and biomarker discovery.